Changyong Hu

556 total citations
17 papers, 360 citations indexed

About

Changyong Hu is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Changyong Hu has authored 17 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Organic Chemistry. Recurrent topics in Changyong Hu's work include Lipid metabolism and biosynthesis (2 papers), Lysosomal Storage Disorders Research (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Changyong Hu is often cited by papers focused on Lipid metabolism and biosynthesis (2 papers), Lysosomal Storage Disorders Research (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Changyong Hu collaborates with scholars based in Singapore, China and United States. Changyong Hu's co-authors include Wei‐Yi Ong, Robert Switzer, Ujendra Kumar, Anita Sidhu, Wei-Yi Ong, Xinrong Lu, Barry Halliwell, Shutish C. Patel, Myung‐Sun Kim and Kyung-Soon Park and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Changyong Hu

15 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changyong Hu Singapore 10 151 112 57 51 43 17 360
Whitfield Jf Canada 8 243 1.6× 43 0.4× 19 0.3× 60 1.2× 26 0.6× 11 385
Barbara Buccinnà Italy 9 254 1.7× 108 1.0× 24 0.4× 34 0.7× 14 0.3× 14 485
Sarah L. Cocklin United States 6 206 1.4× 72 0.6× 24 0.4× 17 0.3× 13 0.3× 8 351
Aya Nonaka Japan 7 451 3.0× 55 0.5× 31 0.5× 43 0.8× 40 0.9× 9 622
Kuo Sc Taiwan 4 189 1.3× 168 1.5× 29 0.5× 21 0.4× 26 0.6× 7 384
Zhengqiu Zhou United States 11 169 1.1× 75 0.7× 23 0.4× 28 0.5× 28 0.7× 18 375
P. G. Oliveira Brazil 9 136 0.9× 98 0.9× 30 0.5× 40 0.8× 22 0.5× 9 332
H. W. Moser United States 11 233 1.5× 144 1.3× 34 0.6× 16 0.3× 27 0.6× 29 372
Tomoya Adachi Japan 5 168 1.1× 37 0.3× 15 0.3× 20 0.4× 44 1.0× 7 366
Jingjing Tao China 10 209 1.4× 39 0.3× 13 0.2× 39 0.8× 9 0.2× 14 313

Countries citing papers authored by Changyong Hu

Since Specialization
Citations

This map shows the geographic impact of Changyong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyong Hu more than expected).

Fields of papers citing papers by Changyong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changyong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyong Hu. The network helps show where Changyong Hu may publish in the future.

Co-authorship network of co-authors of Changyong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Changyong Hu. A scholar is included among the top collaborators of Changyong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changyong Hu. Changyong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ouyang, Feng, Fangfang Sun, Da Luo, et al.. (2025). CIDEC Restricts Liver Regeneration by Disturbing Lipid Droplet Triglyceride Turnover. Advanced Science. 13(3). e07048–e07048.
2.
Su, Hang, Changyong Hu, Jianxia Chen, et al.. (2025). Development of antibody drug conjugates targeting epithelial membrane protein 2-highly expressed lung cancer. Cell Death and Disease. 16(1). 771–771.
3.
Sun, Fangfang, Feng Ouyang, Da Luo, et al.. (2024). Alterations in liver triglyceride profiles in CCl4-induced liver regeneration. Biochemical and Biophysical Research Communications. 734. 150662–150662. 2 indexed citations
4.
Luo, Da, Feng Ouyang, Changyong Hu, et al.. (2024). Branched-chain amino acid catabolism promotes M2 macrophage polarization. Frontiers in Immunology. 15. 1469163–1469163. 10 indexed citations
5.
Zhu, Qing, Da Luo, Liyang Yu, et al.. (2024). CIDEC/FSP27 exacerbates obesity-related abdominal aortic aneurysm by promoting perivascular adipose tissue inflammation. PubMed. 4(1). loae035–loae035. 2 indexed citations
6.
Hu, Changyong, et al.. (2021). Emerging role of SIRT2 in non-small cell lung cancer (Review). Oncology Letters. 22(4). 731–731. 15 indexed citations
7.
Hu, Changyong, Keun‐Bae Lee, Eun Kyoo Song, Myung‐Sun Kim, & Kyung-Soon Park. (2013). Comparison of Bone Tunnel and Suture Anchor Techniques in the Modified Broström Procedure for Chronic Lateral Ankle Instability. The American Journal of Sports Medicine. 41(8). 1877–1884. 43 indexed citations
8.
9.
Goh, Kee Chuan, Changyong Hu, Walter Stünkel, et al.. (2007). SB1317, a Potent and Orally Active FLT3-CDK Inhibitor with High Anti-Tumor Efficacy in Models of Hematological Malignancies.. Blood. 110(11). 1593–1593. 3 indexed citations
10.
Goh, Kee Chuan, Changyong Hu, Hannes Hentze, et al.. (2007). SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders.. Blood. 110(11). 538–538. 11 indexed citations
11.
Yeo, Pauline, Venkatesh Paramesh, Lee Sun New, et al.. (2007). Pharmacokinetic and Pharmacodynamic Properties of SB1317, a Potent and Orally Active Multi-Kinase Inhibitor.. Blood. 110(11). 4201–4201. 1 indexed citations
12.
Liang, Chang‐Hsing, Alex Romero, David Rabuka, et al.. (2005). Structure–activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities. Bioorganic & Medicinal Chemistry Letters. 15(8). 2123–2128. 14 indexed citations
13.
Yao, Sulan, David Rabuka, Changyong Hu, et al.. (2004). Glyco-optimization of aminoglycosides: new aminoglycosides as novel anti-infective agents. Bioorganic & Medicinal Chemistry Letters. 14(14). 3733–3738. 9 indexed citations
14.
Ong, Wei‐Yi, Changyong Hu, & Shutish C. Patel. (2002). Apolipoprotein D in the Niemann-Pick type C disease mouse brain: An ultrastructural immunocytochemical analysis. Journal of Neurocytology. 31(2). 121–129. 16 indexed citations
15.
Ong, Wei-Yi, et al.. (2001). Neurodegeneration in Niemann-Pick type C disease mice. Experimental Brain Research. 141(2). 218–231. 91 indexed citations
16.
Hu, Changyong, Wei-Yi Ong, Ranjini K. Sundaram, Chumpon Chan, & Shutish C. Patel. (2001). Immunocytochemical localization of apolipoprotein D in oligodendrocyte precursor-like cells, perivascular cells, and pericytes in the human cerebral cortex. Journal of Neurocytology. 30(3). 209–218. 25 indexed citations
17.
Ong, Wei‐Yi, Xinrong Lu, Changyong Hu, & Barry Halliwell. (2000). Distribution of hydroxynonenal-modified proteins in the kainate-lesioned rat hippocampus: evidence that hydroxynonenal formation precedes neuronal cell death. Free Radical Biology and Medicine. 28(8). 1214–1221. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Whitfield Jf Breakdown of academic impact, for papers by Barbara Buccinnà Breakdown of academic impact, for papers by Sarah L. Cocklin Breakdown of academic impact, for papers by Aya Nonaka Breakdown of academic impact, for papers by Kuo Sc Breakdown of academic impact, for papers by Zhengqiu Zhou Breakdown of academic impact, for papers by P. G. Oliveira Breakdown of academic impact, for papers by H. W. Moser Breakdown of academic impact, for papers by Tomoya Adachi Breakdown of academic impact, for papers by Jingjing Tao
Rankless by CCL
2026